When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
AcelRx Pharmaceuticals (NASDAQ:ACRX) announces that it does not intend to revise its latest cash-and-stock bid for Tetraphase Pharmaceuticals (NASDAQ:TTPH) and expects the termination of their previously announced merger agreement since the latter's board deemed a competing offer from Melinta Therapeutics (NASDAQ:MLNT) to be superior.
More news on: AcelRx Pharmaceuticals, Inc., Tetraphase Pharmaceuticals, Inc., Melinta Therapeutics, Inc., Healthcare stocks news, Stocks on the move, Merger & acquisition news,